Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
C$0.02
-25.0%
C$0.02
C$0.01
C$0.06
C$1.99M0.37138,001 shs521,000 shs
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
$6,304.00
$0.00
$0.00
N/AN/AN/A8,370 shs
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
$10.98
$10.93
$10.36
$11.40
$171.29M-0.0138,142 shs15,177 shs
LBL
Lattice Biologics
C$0.04
C$0.04
C$0.03
C$0.13
C$5.13MN/A468,022 shs114,000 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
0.00%0.00%0.00%-40.00%-50.00%
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
0.00%0.00%0.00%0.00%0.00%
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
-0.12%-0.09%+0.37%+1.29%+4.57%
LBL
Lattice Biologics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/AN/AN/AN/A
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
LBL
Lattice Biologics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
N/AN/AN/AN/A
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/A
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
3.00
Buy$12.5013.84% Upside
LBL
Lattice Biologics
N/AN/AN/AN/A

Current Analyst Ratings

Latest AQS, EVE, LBL, and ASP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2024
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$13.50 ➝ $12.50
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
C$1.17M1.70C$0.00 per share5.00C($0.03) per share-0.50
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/AN/A
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/AN/AN/AN/A
LBL
Lattice Biologics
C$1.56M3.29N/AN/AC$0.00 per share40.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
-C$3.27M-C$0.02N/AN/AN/A-1,569.60%-83.91%6/4/2024 (Estimated)
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/A0.00N/AN/AN/AN/AN/AN/A
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
LBL
Lattice Biologics
N/A-C$0.01N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
N/AN/AN/AN/AN/A
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/A
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/AN/AN/A
LBL
Lattice Biologics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
138.88
0.12
0.46
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/A
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/AN/AN/A
LBL
Lattice Biologics
N/A
0.02
0.02

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aequus Pharmaceuticals Inc. stock logo
AQS
Aequus Pharmaceuticals
12132.63 millionN/ANot Optionable
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/ANot Optionable
EVe Mobility Acquisition Corp stock logo
EVE
EVe Mobility Acquisition
N/A15.60 million15.15 millionNot Optionable
LBL
Lattice Biologics
N/A128.22 millionN/ANot Optionable

AQS, EVE, LBL, and ASP Headlines

SourceHeadline
IVBIY Innovent Biologics, Inc.IVBIY Innovent Biologics, Inc.
seekingalpha.com - January 10 at 10:36 PM
Magnetic lattice surpriseMagnetic lattice surprise
nature.com - October 28 at 10:28 AM
AbCellera Biologics GAAP EPS of -$0.14, revenue of $12MAbCellera Biologics GAAP EPS of -$0.14, revenue of $12M
seekingalpha.com - May 7 at 7:50 PM
Lattice USB IP CoreLattice USB IP Core
design-reuse.com - April 25 at 10:43 PM
ADMA Biologics Stock (NASDAQ:ADMA), Analyst Ratings, Price Targets, PredictionsADMA Biologics Stock (NASDAQ:ADMA), Analyst Ratings, Price Targets, Predictions
benzinga.com - March 28 at 8:49 PM
Three Part Deep Dive Explains Lattice ICE40 FPGA DetailsThree Part Deep Dive Explains Lattice ICE40 FPGA Details
hackaday.com - March 20 at 9:41 AM
Lattice Biologics Ltd (LBLh)Lattice Biologics Ltd (LBLh)
investing.com - March 2 at 6:07 PM
Lattice Announces Lattice Connect Partner Ecosystem to Help Organizations Maximize People SuccessLattice Announces Lattice Connect Partner Ecosystem to Help Organizations Maximize People Success
markets.businessinsider.com - September 23 at 7:41 PM
Field Architecture clads Silicon Valley synagogue in salvaged-wood latticeField Architecture clads Silicon Valley synagogue in salvaged-wood lattice
dezeen.com - September 12 at 12:13 PM
Lattice Semiconductor Corp LSCC Stock QuoteLattice Semiconductor Corp LSCC Stock Quote
morningstar.com - September 9 at 6:30 PM
Notice of Lattice Biologics Ltd. Year End 2016 Financial Results Conference CallNotice of Lattice Biologics Ltd. Year End 2016 Financial Results Conference Call
finance.yahoo.com - October 26 at 3:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Aequus Pharmaceuticals logo

Aequus Pharmaceuticals

CVE:AQS
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
American Strategic Income Portfolio logo

American Strategic Income Portfolio

NYSE:ASP
American Strategic Income Portfolio Inc. (ASP) invests in mortgage-related assets that directly or indirectly represent a participation in or are secured by and payable from mortgage loans. The Fund may also invest in the United States Government securities, corporate debt securities, preferred stock issued by real estate investment trusts, and mortgage servicing rights. In addition, the Fund may borrow using reverse repurchase agreements and credit facilities. The Fund's primary objective is to achieve high levels of current income. Its secondary objective is to seek capital appreciation. The Barclays Capital Mutual Fund Government/Mortgage Index, ASP's benchmark, consists of all the United States Government agency and Treasury securities and agency mortgage-backed securities. The Fund's investment advisor is U.S. Bancorp Asset Management, Inc. ASP's sub-advisors include Nuveen Asset Management, LLC and Nuveen Fund Advisors, Inc.
EVe Mobility Acquisition logo

EVe Mobility Acquisition

NYSE:EVE
EVe Mobility Acquisition Corp does not have significant operations. The company focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.

Lattice Biologics

CVE:LBL
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.